Showing results (111-120 of 731) with videos related to
Sort By:
Pageof 74
Expert Review of Anticancer Therapy|June 13, 2017
Checkpoint inhibitors in advanced melanoma: effect on the field of immunotherapyAine O'reilly, James LarkinExpert Review of Clinical Pharmacology|February 23, 2017
Lenvatinib for use in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapyAine O'Reilly, James LarkinExpert Opinion on Biological Therapy|January 12, 2016
Combination immune checkpoint blockade with ipilimumab and nivolumab in the management of advanced melanomaLavinia Spain, James LarkinEuropean Urology|July 23, 2014
Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkersSakshi Gulati, Pierre Martinez, Tejal Joshi, et al.Human Molecular Genetics|April 20, 2022
Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma casesBryndis Yngvadottir, Avgi Andreou, Laia Bassaganyas, et al.Nature Communications|July 15, 2024
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinomaRichard Culliford, Samuel E D Lawrence, Charlie Mills, et al.The Lancet. Gastroenterology & Hepatology|June 20, 2020
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitisNick Powell, Hajir Ibraheim, Tim Raine, et al.Breast Cancer Research : BCR|November 7, 2008
Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancerCharles Swanton, Zoltan Szallasi, James D Brenton, et al.The Journal of Pathology|October 12, 2013
Implications of intratumour heterogeneity for treatment stratificationAndrew Crockford, Mariam Jamal-Hanjani, James Hicks, et al.Pageof 74